Faculté des sciences

Epidémiologie de la borréliose de Lyme en Suisse romande

Nahimana, I ; Gern, Lise ; Péter, O ; Praz, G ; Moosmann, Yves ; Francioli, P ; et les responsables de laboratoires

In: Schweizerische medizinische Wochenschrift, 2000, vol. 130, p. 1456-1461

The purpose of this study was to assess the number of cases and the clinical aspects of Lyme borreliosis in French-speaking Switzer- land. From July 1996 to December 1997, all laboratories performing serological tests for Lyme borreliosis sent a questionnaire to the treating physicians whenever the tests were positive. In addition, the physicians who diagnosed a case on clinical grounds only were... More

Add to personal list
    Summary
    The purpose of this study was to assess the number of cases and the clinical aspects of Lyme borreliosis in French-speaking Switzer- land. From July 1996 to December 1997, all laboratories performing serological tests for Lyme borreliosis sent a questionnaire to the treating physicians whenever the tests were positive. In addition, the physicians who diagnosed a case on clinical grounds only were also asked to report these cases.
    During this period, 1460 positive serological tests were recorded among approximately 10 360 performed (14%). A total of 775 questionnaires were returned (53%). In 3 ⁄ 4 of the cases, the test was ordered because of an acute clinical manifestation or a tick bite. The rest related to chronic symptoms or follow-up. In 504 cases (65%), diagnosis was considered certain or probable. These were erythema migrans in 46%, clinical manifestations of stage II in 33% (26 facial palsy, 20 acute arthritis, 5 benign cutaneous lymphocytoma) and chronic symptoms in 21% (23 acrodermatitis, 26 neuropathies, and 8 arthritis). The adjusted incidence, estimated on the basis of the treating physician’s place of residence, ranged from 9/100 000 in Valais to 95/100 000 in Neuchâtel.
    This study indicates that Lyme borreliosis is a diagnosis frequently looked for and established in French-speaking Switzerland. Although erythema migrans is the main clinical manifestation, symptoms of stage II and III indicate that Lyme borreliosis is also responsible for relatively major systemic morbidity.